Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age

Citation

• Curran, D., Athan, E., Diez-Domingo, J., Ghesquiere, W., Heineman, T. C., Lal, H., . . . Johnson, R. W. (2016). Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age. Open Forum Infectious Diseases, 3(suppl_1), 912. doi:10.1093/ofid/ofw194.77

Digital Object Identifier (doi)

• 10.1093/ofid/ofw194.77

Web Of Science Accession Number

Start Page

• 912

Volume

• 3

Issue

• suppl_1

Abstract

UOW Authors

•   Yeo, Wilfred

Publication Date

• 2016

Publisher

• Oxford University Press (OUP) 

Published In

• Open Forum Infectious Diseases  Journal

Citation

• Curran, D., Athan, E., Diez-Domingo, J., Ghesquiere, W., Heineman, T. C., Lal, H., . . . Johnson, R. W. (2016). Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age. Open Forum Infectious Diseases, 3(suppl_1), 912. doi:10.1093/ofid/ofw194.77

Digital Object Identifier (doi)

• 10.1093/ofid/ofw194.77

Web Of Science Accession Number

Start Page

• 912

Volume

• 3

Issue

• suppl_1